Ochre News
NEWS COVERAGE
Leading innovation: 10 promising European startups focusing on biopharmaceuticals
July 26, 2024
Read more
Ochre Bio announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease
April 22, 2024
Read more
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
April 22, 2024
Read more
UK startups are built on immigrant talent, the UK will fail if it forgets this
February 16, 2024
Read more
Ochre Bio with CEO/Co-founder Jack O’Meara and liver expert Dr Scott Friedman, Mount Sinai
November 23, 2023
Read more
Revolutionising Liver Transplants: Can Phenotyping Drive Biotech Transformation in Healthcare?
October 14, 2023
Read more
The intersection between healthcare, technology, strategy and impact – Interview with Ochre Bio’s CEO and co-founder Jack O’Meara
July 24, 2023
Read more
‘I wanted to do something in health but I didn’t want to be a doctor’: Ochre Bio founder Jack O’Meara
May 28, 2023
Read more
Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors
May 17, 2023
Read more
RNA therapies startup Ochre Bio lands $30M to take on chronic liver disease
October 10, 2022
Read more
A liver disease upstart with some global connections and a new R&D strategy reaps a $30M launch round
October 10, 2022
Read more
Chirps, chats and Clubhouses: First-time biotech founders turn to social media for advice, investors and recruitment
April 4, 2022
Read more
‘Day job and a gay job’: LGBTQ+ leaders in biopharma want those who look, talk and love like them to be seen and counted
December 8, 2021
Read more
Biotech looks to upset the preclinical model for liver drug development, and now it’s gearing up for the clinic
June 16, 2021
Read more
Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge
March 24, 2021
Read more
